|
🐜
|
The translational landscape of mTOR signalling steers cancer initiation and metastasis
19 auth.
A. Hsieh,
Yi Liu,
Merritt P. Edlind,
Nicholas T. Ingolia,
M. R. Janes,
A. Sher,
Evan Y. Shi,
C. Stumpf,
Carly Christensen,
M. Bonham,
...
Shunyou Wang,
Pingda Ren,
Michael Martin,
Katti A. Jessen,
M. Feldman,
J. Weissman,
K. Shokat,
C. Rommel,
D. Ruggero
|
10 |
2012 |
10
🐜
|
|
🦁
|
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.
12 auth.
Shunyou Wang,
Jing Gao,
Q. Lei,
N. Rozengurt,
C. Pritchard,
J. Jiao,
...
G. Thomas,
Gang Li,
P. Roy-burman,
P. Nelson,
Xin Liu,
Hong Wu
|
10 |
2003 |
10
🦁
|
|
🐜
|
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.
8 auth.
B. Lin,
C. Ferguson,
James T. White,
Shunyou Wang,
R. Vessella,
L. True,
...
Leroy E. Hood,
Peter S. Nelson
|
9 |
1999 |
9
🐜
|
|
🐜
|
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.
11 auth.
D. Mulholland,
L. Tran,
Yunfeng Li,
Houjian Cai,
Ashkan Morim,
Shunyou Wang,
...
S. Plaisier,
I. Garraway,
Jiaoti Huang,
T. Graeber,
Hong Wu
|
9 |
2011 |
9
🐜
|
|
🦁
|
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation
Shunyou Wang,
Alejandro Garcia,
Michelle Wu,
Devon A. Lawson,
O. Witte,
Hong Wu
|
8 |
2006 |
8
🦁
|
|
🐬
|
PTENless means more.
B. Stiles,
M. Groszer,
Shunyou Wang,
J. Jiao,
Hong Wu
|
7 |
2004 |
7
🐬
|
|
🐜
|
NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
10 auth.
Q. Lei,
J. Jiao,
L. Xin,
Chun-Ju Chang,
Shunyou Wang,
Jing Gao,
...
M. Gleave,
O. Witte,
Xin Liu,
Hong Wu
|
7 |
2006 |
7
🐜
|
|
🐜
|
A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.
20 auth.
P. Majumder,
Chiara Grisanzio,
F. O'Connell,
M. Barry,
Joseph M Brito,
Qing Xu,
Isil Guney,
R. Berger,
P. Herman,
Rachel Bikoff,
...
Giuseppe Fedele,
W. Baek,
Shunyou Wang,
Katharine Ellwood-Yen,
Hong Wu,
C. Sawyers,
S. Signoretti,
W. Hahn,
M. Loda,
W. Sellers
|
7 |
2008 |
7
🐜
|
|
🐜
|
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
7 auth.
J. Jiao,
Shunyou Wang,
R. Qiao,
I. Vivanco,
Philip A Watson,
C. Sawyers,
...
Hong Wu
|
7 |
2007 |
7
🐜
|
|
🐜
|
Increased expression of osteopontin contributes to the progression of prostate cancer.
9 auth.
A. Khodavirdi,
Zhigang Song,
Shangxin Yang,
C. Zhong,
Shunyou Wang,
Hong Wu,
...
C. Pritchard,
P. Nelson,
P. Roy-burman
|
6 |
2006 |
6
🐜
|
|
🐜
|
Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells
15 auth.
J. Jiao,
A. Hindoyan,
Shunyou Wang,
L. Tran,
A. Goldstein,
Devon A. Lawson,
Donghui Chen,
Yunfeng Li,
Changyong Guo,
Baohui Zhang,
...
L. Fazli,
M. Gleave,
O. Witte,
I. Garraway,
Hong Wu
|
6 |
2012 |
6
🐜
|
|
🐜
|
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens
10 auth.
Vanessa C. Thompson,
Tanis G.W. Morris,
D. Cochrane,
J. Cavanagh,
Latif A. Wafa,
T. Hamilton,
...
Shunyou Wang,
L. Fazli,
M. Gleave,
C. Nelson
|
5 |
2006 |
5
🐜
|
